Louisa Degenhardt PhD MPsychology (Clinical), Professor, NHMRC Principal Research Fellow, Stuart Gilmour MPH MStatistics, Assistant Professor, Fiona Shand PhD, Postdoctoral Fellow, Raimondo Bruno PhD, Senior Lecturer, Gabrielle Campbell BCriminology, Senior Research Officer, Richard P. Mattick PhD MPsychology (Clinical), Professor, Briony Larance, BSc Psychology (Hons), PhD, Lecturer, Wayne Hall PhD, Professor and NHMRC Australia Fellow.
Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia
Version of Record online: 25 JUL 2013
© 2013 Australasian Professional Society on Alcohol and other Drugs
Drug and Alcohol Review
Volume 32, Issue 5, pages 468–474, September 2013
How to Cite
Degenhardt, L., Gilmour, S., Shand, F., Bruno, R., Campbell, G., Mattick, R. P., Larance, B. and Hall, W. (2013), Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia. Drug and Alcohol Review, 32: 468–474. doi: 10.1111/dar.12066
- Issue online: 15 SEP 2013
- Version of Record online: 25 JUL 2013
- Manuscript Accepted: 26 JUN 2013
- Manuscript Received: 25 APR 2013
- Australian National Medical Health and Research Council
- Tasmanian Department of Health and Human Services
- NHMRC. Grant Numbers: 1005688, 1022522
- Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund
- Reckitt Benckiser
Appendix SA. Data on people who inject drugs used in estimates.
Table SA1. Data used to make estimates of the number of regular people who inject drugs (PWID), 2004–2010.
Table SA2. People who inject drugs.
Table SA3. Median amounts used on a day of use among those using in the past 6 months.
Table SA4. Median days of opioid use among users of different opioids, 2004–2010.
Appendix SB. Details of time series analyses of opioid prescribing.
Figure SB1.1. High- and medium-rate morphine prescribing states.
Figure SB1.2. Low baseline morphine prescribing.
Figure SB1.3. Low baseline morphine-prescribing states.
Figure SB2.1. Observed and predicted prescribing volumes for ACT, New South Wales and Queensland.
Figure SB2.2. Observed and predicted prescribing volumes for NT, SA and Tasmania.
Figure SB2.3. Observed and predicted prescribing values for Victoria and WA.
Figure SB3.1. High- and medium-rate oxycodone prescribing states.
Figure SB3.2. Medium-rate oxycodone prescribing states.
Figure SB3.3. Low-rate oxycodone prescribing states.
Table SB1.1. Regression results.
Table SB1.2. Overall rates of change after including interactions.
Table SB2.1. Regression results.
Table SB2.2. Baseline average values and monthly percentage change by state.
Table SB3.1. Regression results.
Table SB3.2. Overall rates of change after including interactions.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.